Recent Finacing
Recent Raise
RedHill Biopharma acquires and develops late clinical‑stage formulations of existing drugs, runs Phase II/III trials and partners on formulations for Crohn’s disease, migraine, chemotherapy‑induced nausea, and heart disease.
Focus Areas
Total Raised
Funding round